medac Gesellschaft für klinische Spezialpräparate mbH
9 products tracked · names used in filings: medac Gesellschaft für klinische Spezialpräparate mbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Jivadco trastuzumab duocarmazine | Application withdrawn | |
| 🇪🇺 | Arsenic trioxide medac arsenic trioxide | Authorised | 2020-09-17 |
| 🇪🇺 | Trecondi treosulfan | Authorised | 2019-06-20 |
| 🇪🇺 | Carmustine medac (previously Carmustine Obvius) carmustine | Authorised | 2018-07-18 |
| 🇪🇺 | Pemetrexed medac pemetrexed | Withdrawn | 2015-11-26 |
| 🇪🇺 | Capecitabine Medac capecitabine | Authorised | 2012-11-19 |
| 🇪🇺 | Zoledronic acid medac zoledronic acid | Withdrawn | 2012-08-03 |
| 🇪🇺 | Leflunomide medac leflunomide | Authorised | 2010-07-27 |
| 🇪🇺 | Temomedac temozolomide | Authorised | 2010-01-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.